Virus complement evasion strategies

References

1. Adler R., Glorioso J. C., Cossman J., Levine M. 1978; Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis. Infect Immun 21:442–447
   [Google Scholar]
2. Afonso C. L., Tulman E. R., Lu Z., Zsak L., Osorio F. A., Balinsky C., Kutish G. F., Rock D. L. 2002; The genome of swinepox virus. J Virol 76:783–790
   [Google Scholar]
3. Albrecht J. C., Fleckenstein B. 1992; New member of the multigene family of complement control proteins in herpesvirus saimiri. J Virol 66:3937–3940
   [Google Scholar]
4. Albrecht J. C., Nicolas J., Biller D. & 7 other authors (1992a). Primary structure of the herpesvirus saimiri genome. J Virol 66:5047–5058
   [Google Scholar]
5. Albrecht J. C., Nicolas J., Cameron K. R., Newman C., Fleckenstein B., Honess R. W. 1992b; Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59. Virology 190:527–530
   [Google Scholar]
6. Appleyard G., Hapel A. J., Boulter E. A. 1971; An antigenic difference between intracellular and extracellular rabbitpox virus. J Gen Virol 13:9–17
   [Google Scholar]
7. Atalay R., Zimmermann A., Wagner M., Borst E., Benz C., Messerle M., Hengel H. 2002; Identification and expression of human cytomegalovirus transcription units coding for two distinct Fc gamma receptor homologs. J Virol 76:8596–8608
   [Google Scholar]
8. Barrett J. W., Cao J. X., Hota-Michell S., McFadden G. 2001; Immunomodulatory proteins of myxoma virus. Semin Immunol 13:73–84
   [Google Scholar]
9. Bavari S., Bosio C. M., Wiegand E. 7 other authors 2002; Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 195:593–602
   [Google Scholar]
10. Benichou G., Voisin G. A. 1987; Antibody bipolar bridging: isotype-dependent signals given to guinea pig alveolar macrophages by anti-MHC alloantibodies. Cell Immunol 106:304–317
    [Google Scholar]
11. Bergelson J. M., Chan M., Solomon K. R., St John N. F., Lin H., Finberg R. W. 1994; Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci U S A 91:6245–6249
    [Google Scholar]
12. Betts R. F., Schmidt S. G. 1981; Cytolytic IgM antibody to cytomegalovirus in primary cytomegalovirus infection in humans. J Infect Dis 143:821–826
    [Google Scholar]
13. Cooper N. R., Jensen F. C., Welsh R. M. Jr, Oldstone M. B. 1974; Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J Exp Med 144:970–984
    [Google Scholar]
14. Crnkovic-Mertens I., Messerle M., Milotic I., Szepan U., Kucic N., Krmpotic A., Jonjic S., Koszinowski U. H. 1998; Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J Virol 72:1377–1382
    [Google Scholar]
15. Dorig R. E., Marcil A., Chopra A., Richardson C. D. 1993; The human CD46 molecule is a receptor for measles virus (Edmonston strain. Cell 75:295–305
    [Google Scholar]
16. Dowler K. W., Veltri R. W. 1984; In vitro neutralization of HSV-2: inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR. J Med Virol 13:251–259
    [Google Scholar]
17. Dubin G., Frank I., Friedman H. M. 1990; Herpes simplex virustype 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes. J Virol 64:2725–2731
    [Google Scholar]
18. Dubin G., Socolof E., Frank I., Friedman H. M. 1991; Herpessimplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J Virol 65:7046–7050
    [Google Scholar]
19. Dubin G., Basu S., Mallory D. L. P., Basu M., Tal-Singer R., Friedman H. M. 1994; Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin aggregates. J Virol 68:2478–2486
    [Google Scholar]
20. Ebenbichler C. F., Thielens N. M., Vornhagen R., Marschang P., Arlaud G. J., Dierich M. P. 1991; Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J Exp Med 174:1417–1424
    [Google Scholar]
21. Engelstad M., Howard S. T., Smith G. L. 1992; A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188:801–810
    [Google Scholar]
22. Favoreel H. W., Nauwynck H. J., Van Oostveldt P., Mettenleiter T. C., Pensaert M. B. 1997; Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells. J Virol 71:8254–8261
    [Google Scholar]
23. Favoreel H. W., Nauwynck H. J., Pensaert M. B. 1999a; Role of the cytoplasmic tail of gE in antibody-induced redistribution of viral glycoproteins expressed on pseudorabies virus-infected cells. Virology 259:141–147
    [Google Scholar]
24. Favoreel H. W., Nauwynck H. J., Halewyck H. M., Van Oostveldt P., Mettenleiter T. C., Pensaert M. B. 1999b; Antibody-induced endocytosis of viral glycoproteins and major histocompatibility complex class I on pseudorabies virus-infected monocytes. J Gen Virol 80:1283–1291
    [Google Scholar]
25. Favoreel H. W., Van Minnebruggen G., Nauwynck H. J., Enquist L. W., Pensaert M. B. 2002; A tyrosine-based motif in the cytoplasmic tail of pseudorabies virus glycoprotein B is important for both antibody-induced internalization of viral glycoproteins and efficient cell-to-cell spread. J Virol 76:6845–6851
    [Google Scholar]
26. Fingeroth J. D., Weis J. J., Tedder T. F., Strominger J. L., Biro P. A., Fearon D. T. 1984; Epstein–Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A 81:4510–4514
    [Google Scholar]
27. Fodor W. L., Rollins S. A., Bianco-Caron S., Rother R. P., Guilmette E. R., Burton W. V., Albrecht J. C., Fleckenstein B., Squinto S. P. 1995; The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J Virol 69:3889–3892
    [Google Scholar]
28. Frank I., Friedman H. M. 1989; A novel function of the herpes simplex virus type I Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J Virol 63:4479–4488
    [Google Scholar]
29. Friedman H. M., Cohen G. H., Eisenberg R. J., Seidel C. A., Cines D. B. 1984; Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 309:633–634
    [Google Scholar]
30. Fries L. F., Friedman H. M., Cohen G. H., Eisenberg R. J., Hammer C. H., Frank M. M. 1986; Glycoprotein gC of herpes simplex virus 1 is an inhibitor of the complement cascade. J Immunol 137:1636–1641
    [Google Scholar]
31. Hakozaki Y., Yoshiba M., Sekiyama K. 8 other authors 2002; Mannose-binding lectin and the prognosis of fulminant hepatic failure caused by HBV infection. Liver 22:29–34
    [Google Scholar]
32. Hannan L. A., Edidin M. 1996; Traffic, polarity, and detergent solubility of a glycosylphosphatidylinositol-anchored protein after LDL-deprivation of MDCK cells. J Cell Biol 133:1265–1276
    [Google Scholar]
33. Harris C. L., Spiller O. B., Morgan B. P. 2000; Human and rodent decay-accelerating factors (CD55) are not species restricted intheir complement-inhibiting activities. Immunology 100:462–470
    [Google Scholar]
34. Haurum J. S., Thiel S., Jones I. M., Fischer P. B., Laursen S. B., Jensenius J. C. 1993; Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 7:1307–1313
    [Google Scholar]
35. Herold B. C., WuDunn D., Soltys N., Spear P. G. 1991; Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to the cells and in infectivity. J Virol 65:1090–1098
    [Google Scholar]
36. Hirsch R. L., Griffin D. E., Winkelstein J. A. 1981; Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance. J Immunol 127:1740–1743
    [Google Scholar]
37. Hirsch R. L., Griffin D. E., Winkelstein J. A. 1983; Natural immunity to Sindbis virus is influenced by host tissue sialic acid content. Proc Natl Acad Sci U S A 80:548–550
    [Google Scholar]
38. Howard J., Justus D. E., Totmenin A. V., Schelkunov S., Kotwal G. J. 1998; Molecular mimicry of the inflammation modulatory proteins (IMPs) of poxviruses: evasion of the inflammatory response to preserve viral habitat. J Leukoc Biol 64:68–71
    [Google Scholar]
39. Huemer H. P., Larcher C., Coe N. E. 1992; Pseudorabies virus glycoprotein III derived from virions and infected cells binds to the third component of complement. Virus Res 23:271–280
    [Google Scholar]
40. Huemer H. P., Larcher C., van Drunen Littel-van den Hurk S., Babiuk L. A. 1993; Species selective interaction of Alphaherpesvirinae with the ‘unspecific’ immune system of the host. Arch Virol 130:353–364
    [Google Scholar]
41. Huemer H. P., Nowotny N., Crabb B. S., Meyer H., Hubert P. H. 1995; gp13 (EHV-gC): a complement receptor induced by equine herpesviruses. Virus Res 37:113–126
    [Google Scholar]
42. Hung S. L., Srinivasan S., Friedman H. M., Eisenberg R. J., Cohen G. H. 1992; Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J Virol 66:4013–4027
    [Google Scholar]
43. Hung S. L., Peng C., Kostavasili I., Friedman H. M., Lambris J. D., Eisenberg R. J., Cohen G. H. 1994; The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Virology 203:299–312
    [Google Scholar]
44. Ikeda F., Haraguchi Y., Jinno A., Iino Y., Morishita Y., Shiraki H., Hoshino H. 1998; Human complement component C1q inhibits the infectivity of cell-free HTLV-I. J Immunol 161:5712–5719
    [Google Scholar]
45. Isaacs S. N., Kotwal G. J., Moss B. 1992; Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci U S A 89:628–632
    [Google Scholar]
46. Ishak R., Andiman W. A., Tucker G. 1984; Absence of IgG Fcreceptors on varicella-zoster virus-infected cells. J Med Virol 13:261–267
    [Google Scholar]
47. Janeway C. A., Travers P., Walport M., Shlomchik M. 2001 Immunobiology – The Immune System in Health and Disease NewYork: Garland Publishing;
    [Google Scholar]
48. Johnson D. C., Feenstra V. 1987; Identification of a novel herpesvirus simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. J Virol 61:2208–2216
    [Google Scholar]
49. Johnson D. C., Frame M. C., Ligas M. W., Cross A. M., Stow N.D. 1988; Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol 62:1347–1354
    [Google Scholar]
50. Kapadia S. B., Molina H., van Berckel V., Speck S. H., Virgin H. W. IV 1999; Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J Virol 73:7658–7670
    [Google Scholar]
51. Kase T., Suzuki Y., Kawai T. 7 other authors 1999; Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology 97:385–392
    [Google Scholar]
52. Kostavasili J., Sahu A., Friedman H. M., Eisenberg R. J., Cohen G. H., Lambris J. D. 1997; Mechanism of complement inactivation byglycoprotein C of herpes simplex virus. J Immunol 158:1763–1771
    [Google Scholar]
53. Kotwal G. J., Isaacs S. N., McKenzie R., Frank M. M., Moss B. 1990; Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250:827–830
    [Google Scholar]
54. Kotwal G. J., Miller C. G., Justus D. E. 1998; The inflammation protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation. Mol Cell Biochem 185:39–46
    [Google Scholar]
55. Kubota Y., Gaither T. A., Cason J., Oshea J. J., Lawley T. J. 1987; Characterization of the C3 receptor induced by herpes simplex virus type 1 infection in human epidermal, endothelial, and A431 cells. J Immunol 138:1137–1142
    [Google Scholar]
56. Lee H. J., Essani K., Smith G. L. 2001; The genome sequence of Yaba-like disease virus, a yatapoxvirus. Virology 281:170–192
    [Google Scholar]
57. Lilley B. N., Ploegh H. L., Tirabassi R. S. 2001; Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J Virol 75:11218–11221
    [Google Scholar]
58. Litwin V., Grose C. 1992; Herpesviral Fc receptors and their relationship to the human Fc receptors. Immunol Res 11:226–238
    [Google Scholar]
59. Litwin V., Sandor M., Grose C. 1990; Cell surface expression ofthe varicella-zoster glycoproteins and Fc receptor. Virology 178:263–272
    [Google Scholar]
60. Litwin V., Jackson W., Grose C. 1992; Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J Virol 66:3643–3651
    [Google Scholar]
61. Lubinski J. M., Wang L., Soulika A. M. 7 other authors 1998; Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo . J Virol 72:8257–8263
    [Google Scholar]
62. Lubinski J. M., Wang L., Mastellos D., Sahu A., Lambris J. D., Friedman H. M. 1999; In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J Exp Med 190:1637–1646
    [Google Scholar]
63. Lubinski J. M., Jiang M., Hook L. 7 other authors 2002; Herpes simplex virus type 1 evades the effects of antibody and complement invivo . J Virol 76:9232–9241
    [Google Scholar]
64. MacCormac L. P., Grundy J. P. 1996; Human cytomegalovirus induces an Fc gamma receptor (Fc gammaR) in endothelial cells and fibroblasts that is distinct from the human cellular Fc gammaRs. J Infect Dis 174:1151–1161
    [Google Scholar]
65. Mackowiak P. A., Marling-Cason M. 1987; Immunoreactivity ofcytomegalovirus-induced Fc receptors. Microbiol Immunol 31:427–434
    [Google Scholar]
66. McKenzie R., Kotwal G. J., Moss B., Hammer C. H., Frank M. M. 1992; Regulation of complement activity by vaccinia virus complement-control protein. J Infect Dis 166:1245–1250
    [Google Scholar]
67. Maeda K., Hayashi S., Tanioka Y., Matsumoto Y., Otsuka H. 2002; Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC. Virus Res 84:79–87
    [Google Scholar]
68. Meri S., Pangburn M. K. 1990; Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci U S A 87:3982–3986
    [Google Scholar]
69. Mettenleiter T. C., Zsak L., Zuckermann F., Sugg N., Kern H., Ben-Porat T. 1990; Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus. J Virol 64:278–286
    [Google Scholar]
70. Middeldorp J. M., Jongsma J., The T. H. 1986; Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement. J Infect Dis 153:48–55
    [Google Scholar]
71. Mold C., Bradt B. M., Nemerow G. R., Cooper N. R. 1988; Epstein–Barr virus regulates activation and processing of the third component of complement. J Exp Med 168:949–969
    [Google Scholar]
72. Nagashunmugam T., Lubinski J., Wang L., Goldstein L. T., Weeks B. J., Sundaresan P., Kang E. H., Dubin G., Friedman H. M. 1998; In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol 72:5351–5359
    [Google Scholar]
73. Naniche D., Varior-Krishnan G., Cervoni F., Wild T. F., Rossi B., Rabourdin-Combe C., Gerlier D. 1993; Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67:6025–6032
    [Google Scholar]
74. Nauwynck H. J., Pensaert M. B. 1992; Abortion induced by cell-associated pseudorabies virus in vaccinated sows. Am J Vet Res 53:489–493
    [Google Scholar]
75. Nguyen D. H., Hildreth J. E. 2000; Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 74:3264–3272
    [Google Scholar]
76. Ogata M., Shigeta S. 1979; Appearance of immunoglobulin G Fc receptor in cultured human cells infected with varicella-zoster virus. Infect Immun 26:770–774
    [Google Scholar]
77. Oleszak E. L. 1994; Molecular mimicry between Fc receptors and viral antigens. Arch Immunol Ther Exp 42:83–88
    [Google Scholar]
78. Oleszak E. L., Perlman S., Parr R., Collisson E. W., Leibowitz J. L. 1993; Molecular mimicry between S peplomer proteins of coronaviruses (MHV, BCV, TGEV and IBV) and Fc receptor. Adv Exp Med Biol 342:183–188
    [Google Scholar]
79. Oleszak E. L., Kuzmak J., Hogue B., Parr R., Collisson E. W., Rodkey L. S., Leibowitz J. L. 1995; Molecular mimicry between Fc receptor and S peplomer protein of mouse hepatitis virus, bovine corona virus, and transmissible gastroenteritis virus. Hybridoma 14:1–8
    [Google Scholar]
80. Ono A., Freed E. O. 2001; Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A 98:13925–13930
    [Google Scholar]
81. Pangburn M. K. 1986; Immunobiology of the Complement System . pp  45–62 Edited by Ross G. D. New York: Academic Press;
82. Para M. F., Baucke R. B., Spear P. G. 1982; Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced Fc-binding receptors. J Virol 41:129–136
    [Google Scholar]
83. Perez de la Lastra J. M., Harris C. L., Hinchliffe S. J., Holt D. S., Rushmere N. K., Morgan B. P. 2000; Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats. J Immunol 165:2563–2573
    [Google Scholar]
84. Rahman A. A., Teschner M., Sethi K. K., Brandis H. 1976; Appearance of IgG (Fc) receptor(s) on cultured human fibroblasts infected with human cytomegalovirus. J Immunol 117:253–258
    [Google Scholar]
85. Reading P. C., Morey L. S., Crouch E. C., Anders E. M. 1997; Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 71:8204–8212
    [Google Scholar]
86. Rosengard A. M., Liu Y., Nie Z., Jimenez R. 2002; Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc Natl Acad Sci U S A 99:8808–8813
    [Google Scholar]
87. Rother R. P., Rollins S. A., Fodor W. F., Albrecht J. C., Setter E., Fleckenstein B., Squinto S. P. 1994; Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J Virol 68:730–737
    [Google Scholar]
88. Rushmere N. K., Tomlinson S., Morgan B. P. 1997; Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function. Immunology 90:640–646
    [Google Scholar]
89. Rux A. H., Lou H., Lambris J. D., Friedman H. M., Eisenberg R. J., Cohen G. H. 2002; Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulphate, and complement component C3b. Virology 294:324–332
    [Google Scholar]
90. Saifuddin M., Parker C. J., Peeples M. E., Gorny M. K., Zolla-Opazner S., Ghassemi M., Rooney I. A., Atkinson J. P., Spear G. T. 1995; Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med 182:501–509
    [Google Scholar]
91. Saifuddin M., Hedayati T., Atkinson J. P., Holgiun M. H., Parker C. J., Spear G. T. 1997; Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD64 at levels that protect from complement-mediated destruction. J Gen Virol 78:1907–1911
    [Google Scholar]
92. Sasaki K., Tsutsumi A., Wakamiya N., Ohtani K., Suzuki Y., Watanabe Y., Nakayama N., Koike T. 2000; Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection. Scand J Gastroenterol 35:960–965
    [Google Scholar]
93. Scheiffele P., Rietveld A., Wilk T., Simons K. 1999; Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem 274:2038–2044
    [Google Scholar]
94. Schmelz M., Sodeik B., Ericsson M., Wolffe E. J., Shida H., Hiller G., Griffiths G. 1994; Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol 68:130–147
    [Google Scholar]
95. Schreurs C., Mettenleiter T. C., Zuckermann F., Sugg N., Ben-Porat T. 1988; Glycoprotein gIII of pseudorabies virus is multifunctional. J Virol 62:2251–2257
    [Google Scholar]
96. Seidel-Dugan C., Ponce de Leon M., Friedman H. M., Eisenberg R. J., Cohen G. H. 1990; Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C. J Virol 64:1897–1906
    [Google Scholar]
97. Smiley M. L., Hoxie J. A., Friedman H. M. 1985; Herpes simplex virus type 1 infection of endothelial, epithelial and fibroblast cells induces a receptor for C3b. J Immunol 134:2673–2678
    [Google Scholar]
98. Spear G. T., Lurain N. S., Parker C. J., Ghassemi M., Payne G. H., Saifuddin M. 1995; Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of twounrelated enveloped viruses. Human T cell leukemia/lymphoma virus type 1 (HTLV-1) and human cytomegalovirus (HCMV). J Immunol 155:4376–4381
    [Google Scholar]
99. Spiller O. B., Morgan B. P. 1998; Antibody-independent activation of the classical complement pathway by cytomegalovirus-infected fibroblasts. J Infect Dis 178:1597–1603
    [Google Scholar]
100. Spiller O. B., Morgan B. P., Tufaro F., Devine D. V. 1996; Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells. Eur J Immunol 26:1532–1538
     [Google Scholar]
101. Stannard L. M., Hardie D. R. 1991; An Fc receptor for human immunoglobulin G is located within the tegument of human cytomegalovirus. J Virol 65:3411–3415
     [Google Scholar]
102. Stoiber H., Kacani L., Speth C., Würzner R., Dierich M. P. 2001; The supportive role of complement in HIV pathogenesis. Immunol Rev 180:168–176
     [Google Scholar]
103. Takahashi-Nishimaki F., Funahashi S., Miki K., Hashizume S., Sugimoto M. 1991; Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins. Virology 181:158–164
     [Google Scholar]
104. Thäle R., Lucin P., Schneider K., Eggers M., Koszinowski U. H. 1994; Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J Virol 68:7757–7765
     [Google Scholar]
105. Tooze J., Hollinshead M., Reis B., Radsak K., Kern H. 1993; Progeny vaccinia and human cytomegalovirus particles utilize earlyendosomal cisternae for their envelopes. Eur J Cell Biol 60:163–178
     [Google Scholar]
106. Van den Berg C. W., Morgan B. P. 1994; Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted. J Immunol 152:4095–4101
     [Google Scholar]
107. Vanderplasschen A., Mathew E., Hollinshead M., Sim R. B., Smith G. L. 1998; Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci U S A 95:7544–7549
     [Google Scholar]
108. Van de Walle G. R., Favoreel H. W., Nauwynck H. J., Van Oostveldt P., Pensaert M. B. 2001; Involvement of cellular cytoskeleton components in antibody-induced internalization of viral glycoproteins in pseudorabies virus-infected monocytes. Virology 288:129–138
     [Google Scholar]
109. Vincent S., Gerlier D., Manie S. N. 2000; Measles virus assembly within membrane rafts. J Virol 74:9911–9915
     [Google Scholar]
110. Virgin H. W. IV, Latreille P., Wamsley P., Hallsworth K., Weck K. E., Dal Canto A. J., Speck S. H. 1997; Complete sequence andgenomic analysis of murine gammaherpesvirus 68. J Virol 71:5894–5904
     [Google Scholar]
111. Watkins J. F. 1964; Adsorption of sensitized sheep erythrocytes toHeLa cells infected with herpes simplex virus. Nature 202:1364–1365
     [Google Scholar]
112. Westmoreland D., Watkins J. F. 1974; The IgG receptor induced by herpes simplex virus: studies using radioiodinated IgG. J Gen Virol 24:167–178
     [Google Scholar]